Clinical immunology and immunopathology.
Discontinued
Publisher:
Academic Press,. Orlando, FL : Academic Press (1998)
Frequency: Monthly
Country: United States
Language: English
Start Year:1972 - 1998
Identifiers
| ISSN: | 0090-1229 (Print) 0090-1229 (Linking) |
| NLM ID: | 0356637 |
| (DNLM): | C25740000(s) |
| (OCoLC): | 01784768 |
| Coden: | CLIIAT |
| Classification: | W1 CL715 |
Increased susceptibility of fibroblasts from horses with severe combined immunodeficiency to growth inhibition by 2′-deoxyadenosine. The effect of adenosine, deoxyadenosine, guanosine, and deoxyguanosine on the growth rate of fibroblasts derived from normal horses, horses heterozygous for the severe combined immunodeficiency (SCID) trait (heterozygotes), and horses with SCID was studied. All four purines were found to inhibit growth in a dose-dependent manner, but only adenosine and deoxyadenosine were inhibitory at concentrations of less than 100 microM. No statistical difference in sensitivity to adenosine was detected between normal and SCID fibroblasts. Fibroblasts from SCID horses were, however, more sensitive to the g...
Equine complement activation as a mechanism for equine neutrophil migration in Onchocerca cervicalis infections. Extracts of Onchocerca cervicalis, an equine parasite, were incubated with radiolabeled equine neutrophils and neutrophil migration was assessed for factors derived from the parasite itself or for host-derived factors after incubation of these same parasite extracts with equine serum. No stimulus for cell migration was observed in saline extracts of adult worms, uterine microfilariae, or skin microfilariae at any dosage tested. However, after incubation of saline extracts with fresh normal equine sera a marked stimulus for neutrophil migration was observed. Ablation of this biologic activity w...
Fetal tissue transplantation for immunotherapy of combined immunodeficiency in horses. Six young horses with combined immunodeficiency were given liver cells intravenously or intraperitoneally and thymuses subcutaneously from equine fetuses ranging from 68 to 110 days of gestational age. Three of four horses given cells from fetuses over 90 days of age developed lesions compatible with graft versus host reactions. One horse given cells from an 80-day fetus developed mitogen-responsive lymphocytes, synthesized immunoglobulins of the four major equine classes, and survived to 11.5 months of age. The sixth foal receiving cells from a 68-day fetus showed no discernable effects from ...